BioPharmX Corporation (OTCQB: BPMX) today announced the availability of Violet™ iodine, a new, once-daily pill for relief of premenstrual breast discomfort. The first-of-its-kind product is based on the latest molecular iodine technology designed to help free women from the burden of breast discomfort by addressing the underlying causes of a condition known as fibrocystic breast condition (FBC), with the added benefit of promoting breast health for women of reproductive age.*
*These statements have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7378951-biopharmx-introducing-violet-iodine-premenstrual-breast-discomfort/
Hunova, the first robotic gym for the rehabilitation and functional motor sense evaluation of lower limbs and trunk, has been officially launched in Genoa, Italy. The first 30 robots will be available from June in Europe and the USA. The technology was developed and patented at the IIT laboratories and has been launched on the market thanks to a 10 million euro investment from entrepreneur Sergio Dompè.
Hunova is a programmable robotic medical device that allows professionals in the geriatrics, neurology and sport rehabilitation field to cure and predict many neurological and orthopedic conditions. There are two main competitive advantages of this technology: Hunova is able to collect a significant amount of data on biomechanics, constantly monitoring the patient’s progress. Secondly, it provides direct support to the patient through a guiding robotic system, offering a wide range of rehabilitation protocols in the form of video games. It consists of two electromechanical platforms equipped with sensors, characterized by two degrees of freedom (feet and seat level). The device integrates the force sensors to adjust the interaction with the patient and a wireless sensor, which is placed on the patient’s trunk, allowing the physiotherapist to check the movement of the torso.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8108951-iit-movendo-launch-robot-hunova/
Whether finding creative ways to help fuel their kids in the morning or coming up with smart snacks to help keep their families energized during the day, moms are constantly in search of easy ways to develop healthy habits with their families. To help mom support her family’s active and healthy lifestyles, Kellogg’s® is rolling out Tips for a Great Start: a 30-day program featuring Team Kellogg’s™, a group of U.S. Olympic and Paralympic athletes and hopefuls, and U.S. Olympic Committee (USOC) dietitians.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65070-team-kelloggs-athletes-and-dietitians-tips-for-a-great-start
14 year old Alopecia client.,Houston Lace Eyebrows and Lashes applied a pair of eyebrows and eyelashes to an Alopecia client. She has been without hair since the age of 3 years of age.
www.houstonlacebrows.com
www.myspace.com/houstonlacebrows
For seventeen year old Emerson Cole, life is about seeing what is not there. She has tried everything, but the visions keep coming back. So when her well meaning brother brings in a consultant from a secretive organization called the Hourglass, Emerson is willing to try one last cure. But meeting Michael Weaver may not only change her future, it may also change her past. Learn more about this book here, http://bit.ly/eWLbYv and its author here, http://bit.ly/fihKf9 YA
Blood cancers are the third leading cause of cancer deaths in the U.S. However, many Americans are unaware of the impact of these cancers, including leukemia, lymphoma and myeloma, which affect the bone marrow, the blood cells, the lymph nodes and other parts of the lymphatic system.
A new survey commissioned by The Leukemia & Lymphoma Society (LLS) reveals more than four in five adults (82%) are surprised that blood cancers are the third leading cancer killer of Americans. Further, nearly four in five adults (78%) are surprised that acute lymphocytic leukemia (ALL) is the most common cancer in children and young adults under age 20.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128551-lls-blood-cancer-awareness-month/
Re-fueling at the pump is a constant source of horror for most drivers, with prices of 1.50 euros per liter of Super now the norm. So it only makes sense that our scientists should be searching for a way to cure us of our petroleum addiction. And the solution could come from advanced, high-efficiency electric motors. This is the domain of electric mobility, which has its own dedicated tradeshow at HANNOVER MESSE, the world’s leading industrial technology fair. The latest electric mobility technology promises to save not just money, but the environment as well.
http://www.targetcenteredgolf.com Eric Jones PGA Pro and World Long Drive Champion provides golf swing tips and golf instruction on how to play your most consistent golf. This golf FAQ discusses the importance of a pre-shot routine.
The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center in New York; MD Anderson Cancer Center in Houston; Fondazione Centro San Raffaele in Milan; and South Australian Health & Medical Research Institute in Adelaide.
This $40.3 million investment, comprised of 75 new research grants in LLS’s portfolio of 300 projects, will fund a diverse array of research to find better treatments and cures for patients with leukemia, lymphoma, myeloma and other blood cancers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554855-lls-invests-millions-new-research-treatment-cures/
